Trial intelligence / Profile preview

Herceptin alone or with a taxane as first-line treatment for metastatic HER2-positive breast cancer after relapse following adjuvant Herceptin

2004-000752-17Phase 2Completed

Sponsor

Roche

Start

Jul 2004

Modality

Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1